http://feeds2.feedburner.com/clinicaladvisorevidence-basedmedicine Latest articles from The Clinical Advisor Evidence-Based Medicine Evidence-Based Medicine Evidence-Based Medicine custserv@haymarketmedia.com no There are limited published data on the efficacy and safety of direct-acting oral anticoagulants (DOACs) in patients with end-stage renal disease (ESRD) on dialysis and atrial fibrillation. https://www.clinicaladvisor.com/apixaban-in-patients-with-esrd-and-atrial-fibrillation/article/830398/ Wed, 30 Jan 2019 15:57:22 GMT There are limited published data on the efficacy and safety of direct-acting oral anticoagulants (DOACs) in patients with end-stage renal disease (ESRD) on dialysis and atrial fibrillation. https://www.clinicaladvisor.com/apixaban-in-patients-with-esrd-and-atrial-fibrillation/article/830398/ Questions about the generalizability of previous data on dual antiplatelet therapy after minor ischemic stroke or high-risk transient ischemic attack lead investigators of the POINT trial to conduct a similar study in an international population. https://www.clinicaladvisor.com/assessment-of-dual-antiplatelet-therapy-after-stroke-tia/article/830397/ Wed, 30 Jan 2019 15:33:49 GMT Questions about the generalizability of previous data on dual antiplatelet therapy after minor ischemic stroke or high-risk transient ischemic attack lead investigators of the POINT trial to conduct a similar study in an international population. https://www.clinicaladvisor.com/assessment-of-dual-antiplatelet-therapy-after-stroke-tia/article/830397/ Albiglutide is available in other countries, and this trial may serve as an impetus for its reintroduction in the United States, particularly if follow-up results show a survival advantage with albiglutide. https://www.clinicaladvisor.com/albiglutide-reduces-major-cv-events-in-patients-with-type-ii-diabetes-and-known-cvd/article/830395/ Wed, 30 Jan 2019 15:19:51 GMT Albiglutide is available in other countries, and this trial may serve as an impetus for its reintroduction in the United States, particularly if follow-up results show a survival advantage with albiglutide. https://www.clinicaladvisor.com/albiglutide-reduces-major-cv-events-in-patients-with-type-ii-diabetes-and-known-cvd/article/830395/ Starting with physical therapy and having surgery only if that failed was as effective as immediate surgery in patients with osteoarthritis of the knee. https://www.clinicaladvisor.com/physical-therapy-may-allow-patients-with-meniscal-tears-to-avoid-surgery/article/830389/ Wed, 30 Jan 2019 14:33:30 GMT Starting with physical therapy and having surgery only if that failed was as effective as immediate surgery in patients with osteoarthritis of the knee. https://www.clinicaladvisor.com/physical-therapy-may-allow-patients-with-meniscal-tears-to-avoid-surgery/article/830389/ Although the American Academy of Dermatology recommends the direct application of emollients to the skin in patients with atopic dermatitis, the addition of oils, emollients, or other additives to bath water is not recommended due to insufficient evidence regarding their efficacy. https://www.clinicaladvisor.com/emollient-bath-additives-ineffective-for-pediatric-atopic-dermatitis/article/794206/ Fri, 07 Sep 2018 13:07:18 GMT Although the American Academy of Dermatology recommends the direct application of emollients to the skin in patients with atopic dermatitis, the addition of oils, emollients, or other additives to bath water is not recommended due to insufficient evidence regarding their efficacy. https://www.clinicaladvisor.com/emollient-bath-additives-ineffective-for-pediatric-atopic-dermatitis/article/794206/